FDA KOs Allergan Psoriasis Treatment
119371
US regulators won&#39;t approve Allergan Inc.&#39;s (AGN.N: Quote, Profile, Research) experimental treatment for the skin disorder psoriasis based on the data submitted, the company said on Monday.
555063
NEW YORK  - Genzyme Corp. announced Wednesday that its drug Clolar has been approved by the US Food and Drug Administration (news - web sites) (FDA (news - web sites)) for the treatment of
301333
NEW YORK  - Genzyme Corp. announced  Wednesday that its drug Clolar has been approved by the U.S.  Food and Drug Administration (FDA) for the treatment of  children with difficult or relapsed acute lymphoblastic  leukemia (ALL).
617490
Sanofi-Synthelabo on Friday said it received Food and Drug Administration approval for its Eloxatin to be used with chemotherapy to treat stage 3 colon cancer.
88250
Drug maker Pfizer Inc. reported Tuesday that the Food and Drug Administration approved its Vfend antifungal product to treat a number of Candida infections.
763160
A new inhaled steroid treatment for preventing asthma attacks in young children has been approved by the Food and Drug Administration, the drugmaker Schering-Plough Corp. said Monday.
239484
Biogen Idec Inc. of Cambridge will ask a US advisory committee on July 31 to recommend expanding use of the multiple sclerosis drug, Tysabri, for patients with moderate to severe Crohn's disease. A Food and Drug Administration panel will discuss the risks and benefits of the treatment at a meeting in Gaithersburg, Md., according to a notice posted ...
767499
Tablets containing a combination of the blood pressure medication aliskiren and water pill hydrochlorothiazide have been approved by the Food and Drug Administration
84406
[Health India]: Washington, Dec 29 : The US Food and Drug Administration (FDA) has approved a synthetic form of a sea-shell venom as a novel medicine to treat chronic pain.
157177
WASHINGTON The Food and Drug Administration has agreed to allow broader application of a breast cancer drug. The drug (letrozole) is currently used against advanced breast cancer and the FDA will now allow
250578
Nov. 12, 2004 - An experimental treatment for peanut, milk, and wheat allergies appears to have fared well in lab tests on dogs, markedly reducing the severe allergic response in these animals, say California researchers.
133355
Biogen Idec Inc. and Elan Corp. said yesterday that they have applied to the Food and Drug Administration for approval to sell Tysabri, a multiple sclerosis drug, to treat patients with Crohn's disease.
212798
NEW YORK, December 16  - Specialty pharmaceutical company Sepracor (SEPR.NAS) announced yesterday that it had received the FDA approval for marketing its Lunesta treatment for insomnia.
39561
NEW YORK  - Targretin (bexarotene), a drug  that is used to treat lymphoma of the skin, also appears useful  against the scaly skin condition psoriasis, Dutch researchers  report.
256613
(letrozole) is the first therapy approved by theU.S. Food and Drug Administration (FDA) for the extended adjuvant treatmentof postmenopausal women with early breast cancer who have received adjuvant(post-surgery) tamoxifen therapy for five years
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
485506
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma. Roughly 20,000 Americans have the cancer, Merck said.